Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ocular cicatricial pemphigoid.

D S Holsclaw1

  • 1Francis I. Proctor Foundation, Department of Ophthalmology, University of California, San Fransisco 94143, USA.

International Ophthalmology Clinics
|April 13, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel arginine substitution mutation in 1A domain and a novel 27 bp insertion mutation in 2B domain of keratin 12 gene associated with Meesmann's corneal dystrophy.

The British journal of ophthalmology·2004
Same author

Congenital unilateral pulmonary venous atresia: definitive diagnosis and treatment.

Pediatric cardiology·2002
Same author

Energy expenditure and substrate utilization in adults with cystic fibrosis and diabetes mellitus.

The American journal of clinical nutrition·1999
Same author

Interstitial keratitis.

International ophthalmology clinics·1999
Same author

Breast abnormalities in patients with cystic fibrosis: previously unrecognized changes.

Annals of diagnostic pathology·1998
Same author

Chronic varicella-zoster virus epithelial keratitis in patients with acquired immunodeficiency syndrome.

Archives of ophthalmology (Chicago, Ill. : 1960)·1998
Same journal

Home Tonometry and Perimetry: Addressing an Unmet Need in Glaucoma Care.

International ophthalmology clinics·2026
Same journal

Bleb Revision Techniques for Hypotony Maculopathy: A Review.

International ophthalmology clinics·2026
Same journal

Cyclodialysis Cleft Closure Following Suprachoroidal Spacer Implantation.

International ophthalmology clinics·2026
Same journal

Descemet Membrane Detachment During Ab-Interno Canaloplasty.

International ophthalmology clinics·2026
Same journal

Inflammatory Keratitis and IOP Spike After Repeat SLT in Pseudoexfoliation Glaucoma: Case Report and Literature Review.

International ophthalmology clinics·2026
Same journal

Beyond the Bottle: Lessons From the Laser in Glaucoma and Ocular Hypertension Trial.

International ophthalmology clinics·2026
See all related articles

Ocular cicatricial pemphigoid (OCP) is a severe autoimmune condition affecting the eyes. Early detection and treatment are crucial to prevent irreversible vision loss from conjunctival scarring.

Area of Science:

  • Ophthalmology
  • Autoimmune Diseases
  • Systemic Inflammatory Conditions

Background:

  • Ocular cicatricial pemphigoid (OCP) is a chronic autoimmune disease with potential systemic involvement.
  • Ocular manifestations include bilateral cicatricial conjunctivitis, leading to complications like symblepharon and trichiasis.

Purpose of the Study:

  • To emphasize the importance of early diagnosis and prompt management of OCP.
  • To highlight the need for ophthalmologists to recognize potential systemic and ocular complications.

Main Methods:

  • Review of clinical presentation and management strategies for OCP.
  • Discussion of diagnostic methods including conjunctival biopsy.
  • Emphasis on early intervention for ocular adnexal abnormalities.

Related Experiment Videos

Main Results:

  • OCP can lead to severe ocular surface damage and vision loss if not diagnosed and treated early.
  • Current treatments for advanced disease offer limited visual rehabilitation.
  • Systemic treatment is available but often initiated after significant structural damage.

Conclusions:

  • Early detection of OCP through vigilant screening and biopsy is critical.
  • Prompt systemic therapy and aggressive management of ocular complications are essential to prevent blindness.
  • Focus on early intervention to preserve ocular structures and prevent vision loss in OCP patients.